Syros Pharmaceuticals (SYRS) Q3 2024 Earnings

Jul 31Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-2.18
-1.49
-0.79
-0.1

Details

Expected EPS
-0.76744
Actual EPS
-0.59
Surprise EPS
0.18
Surprise Percent
+23.12%

Description

⁨Syros Pharmaceuticals⁩ (⁦SYRS⁩) has reported earnings of ⁦-0.59⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts